Oncoclinicas do Brasil Asset Resilience Ratio
Oncoclinicas do Brasil asset resilience ratio. Oncoclinicas do Brasil (ONCO3) has an Asset Resilience Ratio of 5.34% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See defensive interval ratio of Oncoclinicas do Brasil to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Oncoclinicas do Brasil (2013–2024)
Asset resilience ratio of Oncoclinicas do Brasil from 2013 to 2024. This chart shows how Oncoclinicas do Brasil's Asset Resilience Ratio has changed over time. Read ONCO3 total debt and obligations for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Oncoclinicas do Brasil's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Oncoclinicas do Brasil balance sheet assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | R$162.75 Million | 1.98% |
| Short-term Investments | R$276.55 Million | 3.36% |
| Total Liquid Assets | R$439.31 Million | 5.34% |
Asset Resilience Insights
- Limited Liquidity: Oncoclinicas do Brasil maintains only 5.34% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Oncoclinicas do Brasil Industry Peers by Asset Resilience Ratio
Compare Oncoclinicas do Brasil's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Ramsay Health Care Ltd
AU:RHC |
Medical Care Facilities | 3.49% |
|
Encompass Health Corp
NYSE:EHC |
Medical Care Facilities | 0.51% |
|
Sienna Senior Living Inc
TO:SIA |
Medical Care Facilities | 0.09% |
|
Regis Healthcare Ltd
AU:REG |
Medical Care Facilities | 2.29% |
|
Pacific Smiles Group Ltd
AU:PSQ |
Medical Care Facilities | 10.35% |
|
CareRx Corp
TO:CRRX |
Medical Care Facilities | 5.50% |
|
Oceania Healthcare Ltd
AU:OCA |
Medical Care Facilities | 0.01% |
|
Rede D'Or São Luiz S.A.
SA:RDOR3 |
Medical Care Facilities | 39.18% |
Oncoclinicas do Brasil Asset Resilience Ratio by Year (2013–2024)
Oncoclinicas do Brasil asset resilience ratio by year from 2013 to 2024. The table below shows the annual Asset Resilience Ratio data for Oncoclinicas do Brasil.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 16.16% | R$1.81 Billion ≈ $355.20 Million |
R$11.20 Billion ≈ $2.20 Billion |
+8.51pp |
| 2023-12-31 | 7.65% | R$702.41 Million ≈ $137.83 Million |
R$9.18 Billion ≈ $1.80 Billion |
-5.09pp |
| 2022-12-31 | 12.74% | R$1.05 Billion ≈ $205.47 Million |
R$8.22 Billion ≈ $1.61 Billion |
-19.85pp |
| 2021-12-31 | 32.59% | R$1.97 Billion ≈ $385.80 Million |
R$6.03 Billion ≈ $1.18 Billion |
+9.89pp |
| 2020-12-31 | 22.70% | R$770.34 Million ≈ $151.16 Million |
R$3.39 Billion ≈ $665.86 Million |
+3.84pp |
| 2019-12-31 | 18.86% | R$397.97 Million ≈ $78.09 Million |
R$2.11 Billion ≈ $414.07 Million |
+7.54pp |
| 2018-12-31 | 11.32% | R$152.65 Million ≈ $29.95 Million |
R$1.35 Billion ≈ $264.56 Million |
+11.28pp |
| 2015-12-31 | 0.04% | R$224.00K ≈ $43.95K |
R$522.46 Million ≈ $102.52 Million |
-1.32pp |
| 2014-12-31 | 1.36% | R$4.91 Million ≈ $962.84K |
R$360.93 Million ≈ $70.82 Million |
+0.41pp |
| 2013-12-31 | 0.95% | R$3.05 Million ≈ $599.25K |
R$320.43 Million ≈ $62.87 Million |
-- |
About Oncoclinicas do Brasil
Oncoclínicas do Brasil Serviços Médicos S.A., together with its subsidiaries, provides oncology, hematology, radiotherapy, and genomics healthcare services in Latin America. The company offers treatment services, including radiotherapy, hormone therapy, immunotherapy, port-a-cath, palliative care, target therapy, breast cancer hormone therapy, bone marrow transplant, non-oncological infusions, ch… Read more